(Q66392891)
Statements
A Phase II Study of Ibrutinib With R-ICE Chemotherapy for Transplant-eligible Relapsed/Refractory Diffuse Large B-cell Lymphoma Followed by Ibrutinib Maintenance in Patients Not Achieving a Complete Response at Pre-transplant Interim Assessment (English)
0 references
13 December 2016
0 references
August 2023
0 references
34
0 references
21 year
0 references
70 year
0 references